These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5686481)

  • 1. Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin.
    Sabath LD; Gerstein DA; Finland M
    N Engl J Med; 1968 Nov; 279(21):1137-9. PubMed ID: 5686481
    [No Abstract]   [Full Text] [Related]  

  • 2. False elevations of serum glutamic-oxalacetic transaminase due to para-aminosalicylic acid.
    Glynn KP; Cafaro AF; Fowler CW; Stead WW
    Ann Intern Med; 1970 Apr; 72(4):525-7. PubMed ID: 5437634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of a screening method of determining serum glutamic-oxalacetic transaminase for the detection of subclinical forms of viral hepatitis].
    Zavate O; Ungureanu A; Cotor F; Ivan A
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(3):489-90. PubMed ID: 7170500
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum glutamic oxalacetic transaminase activity: revised manual and automated methods using diazonnium dyes.
    Amador E; Salvatore AC
    Am J Clin Pathol; 1971 Jun; 55(6):686-97. PubMed ID: 5567018
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum glutamic oxalacetic transaminase activity: revised manual and automated methods using diazonium dyes.
    Amador E; Salvatore C
    Am J Clin Pathol; 1971 Jun; 55(6):686-97. PubMed ID: 5572077
    [No Abstract]   [Full Text] [Related]  

  • 6. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients.
    Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA
    Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of serum glutamic-oxalacetic and serum glutamic-pyruvic transaminases in vascular diseases of the fundus oculi].
    Capperucci G
    Ann Ottalmol Clin Ocul; 1966 Nov; 92(11):1031-44. PubMed ID: 5985607
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a screening method for serum glutamic oxalacetic transaminase.
    Comfort DJ
    Can J Med Technol; 1965 Oct; 27(5):174-8. PubMed ID: 5838121
    [No Abstract]   [Full Text] [Related]  

  • 9. Colorimetric determination of serum glutamic-oxalacetic transaminase activity.
    Healey PJ
    Clin Chim Acta; 1968 Apr; 20(1):165-6. PubMed ID: 5651999
    [No Abstract]   [Full Text] [Related]  

  • 10. A medical non sequitur.
    JAMA; 1969 Mar; 207(12):2274-5. PubMed ID: 5818401
    [No Abstract]   [Full Text] [Related]  

  • 11. An improved automated assay of serum glutamic-oxalacetic transaminase.
    Lombarts AJ; Peters HJ
    Clin Chim Acta; 1971 Dec; 35(2):257-64. PubMed ID: 5125311
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.
    Ito S; Takaoka T; Nakaya Y; Hiasa Y; Mori H; Tanaka K; Ichihara A
    Gastroenterology; 1982 Nov; 83(5):1102-8. PubMed ID: 6288507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum glutamic oxalacetic transaminase activity in cholecystitis.
    Adams JT; Clermont GH; Schwartz SI
    Surgery; 1970 Sep; 68(3):492-7. PubMed ID: 5460521
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum glutamic oxalacetic transaminase assay using the sequential multiple analyzer (SMA 12-30).
    Moore JJ; Sax SM
    Clin Chem; 1969 Aug; 15(8):730-6. PubMed ID: 5808456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glutamic-oxalacetic transaminase and glutamic-pyruvic transaminase activity in the blood of patients with cervical cancer treated with ionizing radiation].
    Patyra R
    Pol Tyg Lek; 1970 Jan; 25(4):128-31. PubMed ID: 5417763
    [No Abstract]   [Full Text] [Related]  

  • 16. Creatine kinase and glutamic oxalacetic transaminase activity in serum: kinetics of change with exercise and effect of physical conditioning.
    Nuttall FQ; Jones B
    J Lab Clin Med; 1968 May; 71(5):847-54. PubMed ID: 5647686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of glutamic-oxalacetic transaminase in the serum of a group of cholecystopathic patients].
    Bonandini A; Giampaglia G; Urbani G
    Minerva Med; 1975 Oct; 66(69):3637-9. PubMed ID: 1187021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications in an automated procedure for serum glutamic oxalacetic transaminase.
    Beyer WF; Locher A
    Am J Med Technol; 1966; 32(6):363-7. PubMed ID: 5979092
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optimal spectrophotometric methods for the determination of serum glutamic-oxalacetic and glutamic-pyruvic transaminase activity in the diagnosis of icetrigenous hepatitis].
    Giusti G; Ruggiero G; Cacciatore L
    G Mal Infett Parassit; 1968 Mar; 20(3):328-30. PubMed ID: 5740977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glutamic-oxalacetic and glutamic-pyruvic transaminase activity behavior in various ocular diseases].
    Arezzi R
    Minerva Oftalmol; 1970; 12(1):11-6. PubMed ID: 5487699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.